Skip to main content

Table 6 New specifications for product release

From: Bone marrow-derived cells for cardiovascular cell therapy: an optimized GMP method based on low-density gradient improves cell purity and function

 

% Lymphocytes

% Monocytes

% Granulocytes

PLT/WBC

Current specification

≥ 25

≥ 4

≤ 75

≤ 40

Updated specification

≥ 30

≥ 8

≤ 55

≤ 10

  1. PLT: Platelets; WBC: White Blood Cells.